Name | Title | Contact Details |
---|
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.
Provide every patient an experience of compassion, quality care, and service excellence at its highest level of customer expectation. Effingham Health is taking local healthcare to the next level by empowering patients to make their own healthcare decisions. We provide state-of-the-art facilities and technology, which are attracting the best physicians and specialists in the region.
“We are a part of the circle of life. It`s as touching and important to be a part of the end of life as it is to be at the beginning. We provide our patients dignity, comfort and quality of life at the end of their journey. Our job is so much more about life than death! Being present during this sacred time is truly and honor, a calling. “ -Jane, LPH Registered Nurse **** Chapters Health System is committed to enhancing the lives of those affected by advancing age or illness. Through our comprehensive system of healthcare choices, we deliver expert care and heartfelt support to guide the community during the aging and end-of-life journey. From hospice and palliative care for adults and children suffering with life-threatening or life-limiting illnesses to in-home and community-based services for frail but independent seniors, Chapters Health offers a wide range of support services along life`s ever-changing landscape. By providing choices, education and guidance, Chapters Health helps enhance the lives of those affected by advancing age or illness. Chapters Health System includes Chapters Health Palliative Care, Chapters Health Pharmacy, Chapters Health Staffing, Good Shepherd Hospice, HPH Home Health, HPH Hospice and LifePath Hospice.
Definitive Healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. Definitive Healthcare`s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market.
Caring Senior Service San Antonio Texas is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.